Matthew Call insider trades
Open-market stock purchases and sales by Matthew Call, Chief Operating Officer at iTeos Therapeutics, Inc, from SEC Form 4 filings since Mar 1, 2021.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- ITOS iTeos Therapeutics, Inc: other filings, last Aug 29, 2025